Skip to main content

Table 1 Chemotherapy regimens for NSCLC

From: A multicenter randomized controlled open-label trial to assess the efficacy of compound kushen injection in combination with single-agent chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer: study protocol for a randomized controlled trial

Chemotherapy regimen Dosage (mg/m2) Medication time
TP:   
Paclitaxel 135–175 D1
Cis-platinum 75 D1
Carboplatin AUC = 5–6 D1
GP:   
Gemcitabine 1,250 D1, D8
Cis-platinum 75 D1
Carboplatin AUC = 5–6 D1
DP:   
Docetaxel 75 D1
Cis-platinum 75 D1
Carboplatin AUC = 5–6 D1
  1. Notes: The dosage of chemotherapy regimens are only for reference, and specific implementation will take clinical application as a standard